No. 99-591V | Fed. Cl. | Mar 22, 2005
OPINION AND ORDER
The Petitioner Ann Marie Ryman (“petitioner” or “Petitioner Ryman”) has moved to review the entitlement decision of Chief Special Master (“CSM”) Golkiewicz denying her compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §§ 300aa-10 — 300aa-34 (2000) (“Vaccine Act”), and directing that judgment be entered for the Respondent the Secretary of Health and Human Services (“respondent”). The petitioner makes three objections. First, the petitioner objects to the CSM’s use of the so-called Stevens factors for establishing causation in “off-table” vaccine injury cases, concluding that the Stevens test is contrary to law. Second, the petitioner ob-jeets to the CSM’s failure to consider the opinions of the petitioner’s treating physicians, concluding that such failure was arbitrary and an abuse of discretion. Third, the petitioner objects to the CSM’s failure to consider the Vaccine Adverse Events Reporting System reports, concluding that such failure was arbitrary and an abuse of discretion. For the reasons set out below the Court sustains the CSM’s entitlement decision denying compensation.
Background
The petitioner suffers from rheumatoid arthritis (“RA”). She received her first hepatitis B vaccination on August 1,1995, at a presummer camp physical. Pet’r’s Ex. 1 (Affidavit of Ann Marie Ryman (“Ryman Deck”) ¶ 1). On December 26, 1995, the petitioner was administered her second hepatitis B vaccine. Id. ¶ 5; Pet’r’s Ex. 2, at 30. Following the second vaccination, the petitioner went to a rheumatologist, who diagnosed her with “auto immune rheumatoid arthritis” at sixteen years of age. Ryman Decl. ¶ 6.
This case is one of five closely-related vaccine compensation petitions, heard before CSM Golkiewicz, all dealing with the issue of whether hepatitis B vaccine causes RA. Of the other, four, judgment was entered against the petitioner without appeal in Ashley v. HHS, No. 01-221V (Fed.Cl. Oct. 20, 2003); the CSM’s decision denying compensation was affirmed by Capizzano v. HHS, 63 Fed. Cl. 227" court="Fed. Cl." date_filed="2004-12-07" href="https://app.midpage.ai/document/capizzano-v-secretary-of-the-department-of-health--human-services-6653304?utm_source=webapp" opinion_id="6653304">63 Fed. Cl. 227 (2004), and by Manville v. HHS, 63 Fed. Cl. 482" court="Fed. Cl." date_filed="2004-11-24" href="https://app.midpage.ai/document/manville-v-secretary-of-the-department-of-health--human-services-6653376?utm_source=webapp" opinion_id="6653376">63 Fed.Cl. 482 (2004); and in Analla v. HHS, No. 99-609V (Fed.Cl. Sept. 13, 2004), the petition was remanded for the sole purpose of documenting the facts. The CSM complied with that order on October 22, 2004.
Discussion
When reviewing a decision of a special master, the Court inquires into whether any of the findings of fact or conclusions of law are arbitrary or capricious,
Vaccine Act litigation can be divided into two types of cases: table and off-table. Table cases are those where the complained-of injury is listed in 42 U.S.C. § 300aa-14. In these cases, the petitioner enjoys the presumption of causation, and the respondent must show that the vaccine did not cause the injury. In contrast, off-table cases are those where the complained-of injury is not listed in 42 U.S.C. § 300aa-14. In these cases, the petitioner enjoys no presumption; he or she must establish by a preponderance of the evidence that the vaccine was both a “but-for” cause of the injury and a substantial factor in bringing about the injury. Shyface v. Sec’y of HHS, 165 F.3d 1344" court="Fed. Cir." date_filed="1999-01-14" href="https://app.midpage.ai/document/june-shyface-and-patricia-shyface-as-legal-representatives-of-the-estate-of-cheyenne-michael-shyface-v-secretary-of-health-and-human-services-760930?utm_source=webapp" opinion_id="760930">165 F.3d 1344, 1352 (Fed. Cir.1999). This showing must include a “logical sequence of cause and effect.” Grant v. Sec’y of HHS, 956 F.2d 1144" court="Fed. Cir." date_filed="1992-02-25" href="https://app.midpage.ai/document/james-grant-v-secretary-of-the-department-of-health-577796?utm_source=webapp" opinion_id="577796">956 F.2d 1144, 1148 (Fed.Cir. 1992).
Objection One: the Stevens factors
The petitioner contends that the use of the Stevens
The CSM incorporated into his entitlement decision the legal reasoning and conclusions of his decision in the related case of Capizza-no v. HHS, 2004 WL 1399178, 2004 U.S. Claims LEXIS 149 (Fed.Cl. Ch. Spec. Mstr. June 8, 2004), sust’d Capizzano v. HHS, 63 Fed. Cl. 227" court="Fed. Cl." date_filed="2004-12-07" href="https://app.midpage.ai/document/capizzano-v-secretary-of-the-department-of-health--human-services-6653304?utm_source=webapp" opinion_id="6653304">63 Fed.Cl. 227 (2004). See Ryman v. HHS, No. 99-591V, at *7 (Fed.Cl. Ch. Spec.Mstr. Sept. 24, 2004) (unpublished decision). Therefore, the Court shall first review the relevant portions of the CSM’s entitlement decision in Capizzano before proceeding to the application of that case’s analysis to Petitioner Ry-man’s case.
Eschewing the somewhat controversial Stevens factors, the CSM in Capizzano recited the well-known standards for off-table causation in vaccine eases. The CSM explained that the essential standard is that the petitioner must show that it is more likely than not that the vaccine caused the injury. This is usually established by reference to a legitimate medical theory that causally connects the vaccination to the injury. The medical theory must be substantiated by proof of a logical sequence of cause and effect. In sum, the petitioner must show both but-for and substantial factor causation. Capizzano at *3, 2004 U.S. Claims LEXIS 149 at *11—*13. The Court finds nothing exceptionable about the CSM’s recitation of the applicable legal standard.
The CSM went on to discuss the Stevens factors. At the outset, he stated the clear preference for epidemiological studies to prove causation-in-fact. In the absence of such “golden” and rare evidence, the CSM concluded that causation can be proved circumstantially, with reference to the following five factors: medical plausibility; consensus of the medical community as to biologic plausibility; type-injury; a medically acceptable time-frame for onset; and an absence of other likely factors. Id. at *4, 2004 U.S. Claims LEXIS 149 at *17-*19.
Without leaving a stone unturned, the CSM addressed the Court’s strong critique of the Stevens factors in Althen v. HHS, 58 Fed. Cl. 270" court="Fed. Cl." date_filed="2003-09-30" href="https://app.midpage.ai/document/althen-v-secretary-of-department-of-health--human-services-6652240?utm_source=webapp" opinion_id="6652240">58 Fed.Cl. 270 (2003). In Althen, the Court
Beginning his own causation analysis, the CSM noted that the case law did not contain an accepted definition of “logical sequence of cause and effect.” Id. at *7, 2004 U.S. Claims LEXIS 149 at *30. He reviewed the numerous ways in which off-table causation — i.e., causation-in-fact — can be established: epidemiological studies; pathological markers
Where the epidemiological evidence does not support eausation-in-fact, the CSM reasoned that recovery can still be had by proving causation circumstantially. Such a showing consists of: (1) the existence of a biologic mechanism
Turning to the evidence presented at the joint hearing, the CSM determined that it was biologically plausible that hepatitis B vaccine causes RA. He made this finding relying upon the Maillefert study,
Although Petitioner Capizzano established biologic plausibility, the CSM concluded that she failed to prove rechallenge because of inadequacies in the petitioner’s expert evidence. The CSM noted a number of difficulties with Dr. Bell’s testimony. First, Dr. Bell could not explain why a well-respected RA textbook asserted that the incidence of RA may be decreasing with time. See Transcript (“Tr.”) (June 11, 2003) at 51. Second, Dr. Bell relied mainly upon case reports in crafting his theory, and case reports are the least rehable type of evidence for establishing vaccine injury causation. Id. at 51-52. Third, Dr. Bell could not cite any discussion in the medical literature within the last twelve months mentioning a connection between the vaccine and RA. Capizzano at *20-21, 2004 U.S. Claims LEXIS 149 at *73-*74. See Tr. at 246 (testimony of Dr. Phillips). The respondent’s experts, Drs. Phillips and Zweiman, offered testimony discrediting Dr. Bell’s theory. Capizzano at *21-22, 2004 U.S. Claims LEXIS 149 at *74-*76. See Tr. at 153-54 (testimony of Dr. Moulton). And the CSM cited other evidence showing that the medical community has yet to recognize a relationship between the hepatitis B vaccine and RA. See Capizzano at *22-23, 2004 U.S. Claims LEXIS 149 at *79-*80. See Tr. at 44.
Addressing the data upon which Dr. Bell relied, the CSM noted that Vaccine Adverse Event Reporting System (‘VAERS”) evi
The CSM applied this analysis to Petitioner Ryman’s case. Ryman at *11-*12. The petitioner offered no epidemiological study. She did not identify any genetic markers. She failed to prove that her expert’s proposed biologic mechanism occurred in her. She did not establish that the medical community generally accepts the existence of a causal connection between RA and hepatitis B vaccine. And she failed to prove a logical sequence of cause and effect linking the vaccine to her injury. Id. at *12. The CSM also noted that the record supported other causes for her injury. The petitioner’s May 1996 medical records indicate that she had chronic low back, knee and ankle pain, and had suffered gymnastics injuries. Id. See Pet’r’s Ex. 2, at 25, 40. In light of this evidence, the CSM determined that the petitioner had failed to prove by a preponderance that the hepatitis B vaccine caused her RA. See Ryman at *12.
The Court finds no legal error in the CSM’s analysis or its application to the petitioner’s case. Contrary to the petitioner’s contention, the CSM did not apply the Stevens factors, although he did reference them in Capizzano and Ryman. See Capizzano, 63 Fed.Cl. at 230; Ryman at *3. The CSM recited the proper standard in Capizzano. 2004 WL 1399178, *3, 2004 U.S. Claims LEXIS 149, *11-*14. And he applied that standard to this case. Far from limiting his analysis to a pre-defined framework, the CSM searched through the record trying to find any basis for causation. He found nothing that would support a logical sequence of cause and effect. Neither can this Court.
The CSM’s analysis also is consistent with the standards for expert testimony enunciated in Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579" court="SCOTUS" date_filed="1993-06-28" href="https://app.midpage.ai/document/daubert-v-merrell-dow-pharmaceuticals-inc-112903?utm_source=webapp" opinion_id="112903">509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993). In Daubert, the Supreme Court assigned the trial judge a “gate-keeping” function to ensure the reliability of evidence presented to the trier-of-fact. The CSM, of course, performs this same function when he determines whether a particular petitioner’s expert medical testimony supporting biologic probability may be admitted or credited or otherwise relied upon. See Vaccine Rule 8(c) (“The special master will consider all relevant, reliable evidence, governed by principles of fundamental fairness to both parties”) (emphasis added); Terran v. HHS, 195 F.3d 1302" court="Fed. Cir." date_filed="1999-10-27" href="https://app.midpage.ai/document/michele-y-terran-as-legal-representative-of-julie-f-terran-a-minor-v-secretary-of-health-and-human-services-766698?utm_source=webapp" opinion_id="766698">195 F.3d 1302, 1316 (Fed.Cir.1999) (special masters guided by Daubert).
Daubert sets forth several factors by which the admissibility of expert testimony is to be adjudged: (1) whether a theory or technique can or has been tested; (2) whether the theory or technique has been subjected to peer review and publication; (3) whether the theory or technique has a known or potential rate of error and whether standards exist for controlling that risk of error; and (4) whether the theory or technique is generally accepted in the relevant scholarly or professional community. See Daubert, 509 U.S. 579" court="SCOTUS" date_filed="1993-06-28" href="https://app.midpage.ai/document/daubert-v-merrell-dow-pharmaceuticals-inc-112903?utm_source=webapp" opinion_id="112903">509 U.S. at 592-95, 113 S.Ct. 2786; Terran, 195 F.3d 1302" court="Fed. Cir." date_filed="1999-10-27" href="https://app.midpage.ai/document/michele-y-terran-as-legal-representative-of-julie-f-terran-a-minor-v-secretary-of-health-and-human-services-766698?utm_source=webapp" opinion_id="766698">195 F.3d at 1316 n. 2. The flexible standards set forth in the Stevens test essentially encapsulate the important considerations that the Daubert factors impose upon “gate-keepers.” The Stevens factors concerning biologic plausibility and confirmation by medical literature are at bottom reformulations of all the Daubert factors made applicable to vaccine cases. The Stevens factors concerning proof of injury and acceptable temporal relationship are means by which the CSM can determine if the legitimate medical mechanism proposed by the petitioner can likely be applied to the
Considering all the medical evidence before him, the CSM diligently applied the “logical sequence” test required by precedent. His analysis was no doubt influenced by the Stevens factors, but it was not dictated by them. Moreover, the Court can find no error in the CSM’s using his considerable experience in vaccine cases to formulate a framework by which he can analyze the evidence presented, and, at the same time, give parties fair notice of how they should structure their cases. By organizing the analytical criteria that have been developed over the course of many years’ worth of fact-finding, the CSM has made more articulate— and, hence, transparent — the otherwise tacit process of factual determination. In this endeavor the CSM should be lauded. The record supports the CSM’s determination that the petitioner has not established the existence of a plausible biologic mechanism occurring in her. Tr. at 40, 290; Pet’r’s Ex. 2, at 27. Similarly justified was the CSM’s discounting of Dr. Schned’s testimony purportedly supporting rechallenge. Compare Pet’r’s Ex. 2, at 14 with Pet’r’s Ex. 2, at 28. The CSM’s rejection of Dr. Bell’s theory, because insufficiently corroborated by independent peer review, was in accordance with law. The Court agrees with the analysis set forth in Manville, affirming the CSM’s entitlement decision and discussing the deference the special masters enjoy in fact-finding:
With this wide berth charted for his analysis, the chief special master did'not act arbitrarily and capriciously when reviewing the facts of petitioner’s case. The [deferential standard] is illustrative of the medical evidence available to the chief special master, and his acknowledgment of it and discussion of its probative value are sufficient to pass muster under the arbitrary and capricious standard.
Id. at 494. Accordingly, the Court denies the petitioner’s first objection.
Objection Two: failure to consider opinions of treating physicians
The petitioner objects to the CSM’s decision not to credit Dr. Schned’s subjective medical history. The CSM found several difficulties with Dr. Schned’s account. First, Dr. Schned reported that the petitioner received her two vaccinations in the Spring or Summer of 1995, Pet’r’s Ex. 2, at 14, when in fact she received them in August and December of 1995. Ryman Decl. ¶¶ 1, 5. Second, Dr. Schned reported that the petitioner completed the vaccination series prior to her canoe trip, Pet’r’s Ex. 2, at 14, when in fact she received only the first vaccination prior to summer camp. Ryman Decl. ¶ 1. Third, Dr. Schned implied that the petitioner was diagnosed with “trigger finger” shortly after the canoe trip, Pet’r’s Ex. 2, at 14, when in fact she was not diagnosed until December, 1995. Ryman at *9; Pet’r’s Ex. 2, at 28. The CSM was also concerned that Dr. Schned’s account was written one year after the second vaccination. The CSM conceded that Dr. Schned’s account of the onset of the petitioner’s “trigger finger” could support a finding of rechallenge, but the estimated time-frame — four or five months — could place onset either before or after vaccination. Id. at *9-*10. The CSM concluded that Dr. Schned’s account was not probative of rechallenge.
The Court finds no error in the CSM’s analysis or in his weighing of evidence. As noted in the entitlement decision, the ease law expresses a preference for contemporary medical history, not subjective recounting. See Cucuras v. Sec’y of HHS, 993 F.2d 1525" court="Fed. Cir." date_filed="1993-05-14" href="https://app.midpage.ai/document/john-cucuras-and-maria-cucuras-parents-and-next-friends-of-nicole-cucuras-v-secretary-of-the-department-of-health-and-human-services-607196?utm_source=webapp" opinion_id="607196">993 F.2d 1525, 1526-27 (Fed. Cir.1993). And where the medical evidence of causation is in dispute, a high level of deference is due the CSM’s fact-finding. See Hodges v. HHS, 9 F.3d 958" court="Fed. Cir." date_filed="1993-11-15" href="https://app.midpage.ai/document/edwin-hodges-v-secretary-of-the-department-of-health-657267?utm_source=webapp" opinion_id="657267">9 F.3d 958, 961 (Fed.Cir.1993). The CSM was also within his discretion to discount the
While the Court might have weighed the evidence differently, or perhaps not given as much consideration to the inconsistencies in the petitioner’s affidavit as did the CSM, this is entirely beside the point. In fact-finding, the special masters receive deference from the Court unless they have acted arbitrarily or capriciously. The CSM’s discounting of both the petitioner’s affidavit and Dr. Schned’s subjective medical history was neither arbitrary nor capricious.
The CSM’s discounting of Dr. Bell’s theories also was perfectly proper given that, by his own admission, Dr. Bell’s biologic mechanism theory depended entirely upon the petitioner’s affidavit. See Ryman at *11; Tr. at 290. Dr. Bell implied that proof of RA rechallenge for hepatitis B vaccinations required that symptoms appear within thirty days of the second exposure. See Ryman at *8; Tr. at 40. The petitioner sought medical help for joint pain in April, 1996, three months after the second vaccination. Ry-man at *8; Pet’r’s Ex.2, at 27. Hence, it is . clear from the foregoing that the CSM did not impose upon the petitioner some insurmountable burden to establish causation. He abided by the “logical sequence” test, but found that the petitioner’s evidence could not substantiate her expert’s theories. The petitioner’s second objection concerns at heart the deference owed to the CSM’s fact-finding. The CSM explained in his entitlement decision that:
[w]hat may appear to be unreasonable nitpicking of petitioner’s affidavit is in reality the critical determination of the substance of petitioner’s case. The absence of corroborating notations in the medical records, the several contradictory documents regarding the timing of events, and the absence of any explanatory testimony leads the undersigned to the firm and inescapable conclusion that the contemporaneous medical records are to be relied upon for the facts of this case... It must follow, therefore, that petitioner’s affidavit is found to be inherently unreliable. [H] With these findings, because the undersigned cannot rely on petitioner’s affidavit, [her] case of rechallenge must fail.
Id. at *11. As the Capizzano Court stated in affirming the CSM’s entitlement decision, “special masters have wide discretion with respect to the evidence they would consider and the weight to be assigned that evidence.” 63 Fed.Cl. at 231 (citing Whitecotton v. HHS, 81 F.3d 1099" court="Fed. Cir." date_filed="1996-06-26" href="https://app.midpage.ai/document/margaret-whitecotton-by-her-next-friends-kay-whitecotton-and-michael-whitecotton-v-secretary-of-health-and-human-services-716712?utm_source=webapp" opinion_id="716712">81 F.3d 1099, 1108 (Fed.Cir.1996); Burns v. HHS, 3 F.3d 415" court="Fed. Cir." date_filed="1993-08-16" href="https://app.midpage.ai/document/ryan-burns-by-his-mother-and-next-friend-donna-burns-v-secretary-of-the-department-of-health-and-human-services-628695?utm_source=webapp" opinion_id="628695">3 F.3d 415, 416-17 (Fed.Cir.1993); Munn v. HHS, 970 F.2d 863" court="Fed. Cir." date_filed="1992-07-23" href="https://app.midpage.ai/document/lisa-munn-personal-representative-of-the-estate-of-chelsea-vukelich-v-the-secretary-of-the-department-of-health-and-human-services-587397?utm_source=webapp" opinion_id="587397">970 F.2d at 871). In the CSM’s weighing of Dr. Bell’s theories, Dr. Schned’s medical history, and the petitioner’s affidavit, the Court finds no error. The petitioner’s second objection is denied.
The petitioner objects to the CSM’s decision not to accord substantial weight to the VAERS reports, which allegedly establish a causal link between hepatitis B vaccine and RA. See Capizzano at *24, 2004 U.S. Claims LEXIS 149 at *84-*86. As was noted above, the CSM found several difficulties with the VAERS reports. First, the reports can be filed by anyone. Resp.’s Ex. KK, at 191. Second, the quantity and quality of information obtained in the reports is often insufficient to make an informed decision as to whether a causal link exists between the vaccination and the injury. See id. at 192. Third, the reports may be biased towards pre-existing notions of adverse events. Id. at 200. Fourth, the respondent’s expert Dr. Moulton, a biostatistician, testified that VAERS reports “offer very little information regarding causality.” Capizzano at *24, 2004 U.S. Claims LEXIS 149 at *85; Tr. at 119.
The CSM did not entirely discount the VAERS reports, but he did state that, despite the eleven months given Petitioner Capizzano (and Petitioner Ryman) to supplement the record, no additional evidence was presented to show a causal link. This failure to amplify the record was especially noteworthy to the CSM given that the number of hepatitis B vaccinations is increasing. Cap-izzano at *24, 2004 U.S. Claims LEXIS 149 at *85. He reasoned, with good cause, that one ought to expect the number of incidents of RA following hepatitis B vaccination to increase if the number of vaccinations is also increasing. The petitioner’s VAERs objection was also raised before the Manville and Capizzano Courts, and both determined that the CSM’s discounting of the reports was well within his discretion. See Manville at 494; Capizzano, 63 Fed.Cl. at 231. This Court is in agreement: the CSM did not act arbitrarily or capriciously in refusing to accord substantial weight to the VAERS reports. The petitioner’s third objection is denied.
Conclusion
Having reviewed the record and considered the petition’s objections, the Court finds no error in the CSM’s entitlement decision. The CSM applied the proper legal standard for determining causation in off-table cases. The CSM acted within his discretion in discounting the evidentiary weight of the petitioner’s affidavit, Dr. Schned’s medical history, and the VAERS reports. The CSM also properly declined to follow Dr. Bell’s theories, given the latter’s express reliance on the petitioner’s affidavit.
Accordingly, the entitlement decision of the CSM is SUSTAINED. The petition for review is DISMISSED with prejudice. The Clerk of Court is directed to enter judgment for the respondent.
IT IS SO ORDERED.
. The Federal Circuit has noted that, in Vaccine Act litigation, “no uniform definition of [the arbitrary and capricious] standard has emerged.” Hines v. Sec’y of HHS, 940 F.2d 1518" court="Fed. Cir." date_filed="1991-07-31" href="https://app.midpage.ai/document/melissa-hines-on-behalf-of-her-minor-daughter-amber-sevier-v-secretary-of-the-department-of-health-and-human-services-566105?utm_source=webapp" opinion_id="566105">940 F.2d 1518, 1527 (Fed.Cir.1991). Nevertheless, if "the special master has considered the relevant evidence of record, drawn plausible inferences and articulated a rational basis for the decision, reversible error will be extremely difficult to demonstrate.” Id. at 1528.
. The Stevens factors were first published in the CSM’s entitlement decision in Stevens v. Sec’y of HHS, 2001 WL 387418, *23-26, 2001 U.S. Claims LEXIS 67, *91-*113 (Fed.Cl. Ch. Spec. Mstr. March 30, 2001).
. Such was the opinion of the Court in Althen v. United. States, 58 Fed.Cl. 270, 281-82 (2003).
. These include the identification of any genetic predisposition to a disease, which may then be linked to the hypothesized cause of injury.
. "A rechallenge case is one where adverse symptoms are noted after a dose of the vaccine, an additional dose of the vaccine is given, and the symptoms worsen.” Ryman v. HHS, No. 99-591V, at *4 n. 6 (Fed.Cl. Ch. Spec.Mstr. Sept. 24, 2004) (unpublished decision).
. A biologic mechanism is a medically plausible process by which a component of a vaccine can cause a particular injury.
. J.F. Maillerfert, J. Sibilia, et al. Rheumatic disorders developed after hepatitis B vaccination, 38 Rheumatology 978 (1999), Resp.’s Ex. L.
. The petitioner suggests that this Court follow the causation standard set forth in Golub v. HHS, 243 F.3d 561 (Fed.Cir.2000) (table). This is an unpublished opinion, which cannot be cited or accorded precedential weight before the Federal Circuit. See Rule 47.6(b) of the Rules of the United States Court of Appeals for the Federal Circuit. Accordingly, this Court shall disregard Golub and continue to adhere to the existing, binding precedent of the Federal Circuit.